Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term General disorders and administration site conditions
ADR ID BADD_A01804
ADR Hierarchy
08      General disorders and administration site conditions
Description Not Available
MedDRA Code 10018065
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00260Betamethasone0.004821%
BADD_D00261Betamethasone dipropionate--
BADD_D00262Betamethasone valerate--
BADD_D00263Betaxolol--
BADD_D00264Betaxolol hydrochloride--
BADD_D00265Bethanechol--
BADD_D00266Bethanechol chloride--
BADD_D00267Betiatide--
BADD_D00268Bevacizumab--
BADD_D00269Bexarotene0.003839%
BADD_D00270Bezafibrate--
BADD_D00271Bicalutamide0.160854%
BADD_D00272Bicisate dihydrochloride--
BADD_D00273Biguanide--
BADD_D00274Bimatoprost0.142064%
BADD_D00276Bisacodyl--
BADD_D00277Bisoprolol0.068257%
BADD_D00278Bisoprolol fumarate--
BADD_D00279Bivalirudin--
BADD_D00280Bleomycin--
BADD_D00281Bleomycin sulfate--
BADD_D00282Blinatumomab--
BADD_D00283Boceprevir--
BADD_D00284Bortezomib0.079492%
BADD_D00285Bosentan0.215953%
BADD_D00286Bosutinib0.070403%
BADD_D00287Bosutinib monohydrate--
BADD_D00288Botric acid--
BADD_D00289Botulinum neurotoxin a/b immune globulin (human)--
BADD_D00290Botulinum toxin type a--
The 9th Page    First    Pre   9 10 11 12 13    Next   Last    Total 82 Pages